Non small cell lung cancer medical therapy stage I: Difference between revisions
(Mahshid) |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Therapies for non-small cell lung cancer stage I | Therapies for non-small cell lung cancer stage I include [[surgery]], [[radiation therapy]], or [[surgery]] and [[chemotherapy]] (if the tumor size is larger than 4cm). | ||
==Management Approach for Stage I Non-Small Cell Lung Cancer== | ==Management Approach for Stage I Non-Small Cell Lung Cancer== | ||
Line 11: | Line 11: | ||
{{familytree/start}} | {{familytree/start}} | ||
{{familytree | | | | | | | | | | A01 | | |A01= | {{familytree | | | | | | | | | | A01 | | |A01=Is the [[tumor]] central or peripheral?}} | ||
{{familytree | | | | | | |,|-|-|-|^|-|-|.| | | | |}} | {{familytree | | | | | | |,|-|-|-|^|-|-|.| | | | |}} | ||
{{familytree | | | | | | B01 | | | | | B02 | | | B01=Peripheral|B02=Central}} | {{familytree | | | | | | B01 | | | | | B02 | | | B01=Peripheral|B02=Central}} |
Latest revision as of 23:18, 23 February 2018
Non Small Cell Lung Cancer Microchapters |
Differentiating Non Small Cell Lung Cancer from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Non small cell lung cancer medical therapy stage I On the Web |
American Roentgen Ray Society Images of Non small cell lung cancer medical therapy stage I |
Non small cell lung cancer medical therapy stage I in the news |
Directions to Hospitals Treating Non small cell carcinoma of the lung |
Risk calculators and risk factors for Non small cell lung cancer medical therapy stage I |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alonso Alvarado, M.D. [2]Maria Fernanda Villarreal, M.D. [3]
Overview
Therapies for non-small cell lung cancer stage I include surgery, radiation therapy, or surgery and chemotherapy (if the tumor size is larger than 4cm).
Management Approach for Stage I Non-Small Cell Lung Cancer
Shown below is the algorithm on the treatment of the stage I non-small cell lung cancer based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.[1]
Is the tumor central or peripheral? | |||||||||||||||||||||||||||||||||||||||||||
Peripheral | Central | ||||||||||||||||||||||||||||||||||||||||||
Is the tumor T1 or T2a? | |||||||||||||||||||||||||||||||||||||||||||
T1ab, N0 | T2a, N0 | T1ab-2a, N0 | |||||||||||||||||||||||||||||||||||||||||
Perform a pretreatment evaluation
| Perform a pretreatment evaluation | ||||||||||||||||||||||||||||||||||||||||||
Does the pathological evaluation showed positive disease in the mediastinal lymph nodes? | Does the pathological evaluation showed positive disease in the mediastinal lymph nodes? | ||||||||||||||||||||||||||||||||||||||||||
Yes | No | Yes | No | ||||||||||||||||||||||||||||||||||||||||
Click here for the stage III treatment | Is the tumor operable? | Click here for the stage III treatment | Is the tumor operable? | ||||||||||||||||||||||||||||||||||||||||
Yes | No | Yes | No | ||||||||||||||||||||||||||||||||||||||||
Surgical resection + lymph node dissection | stereotactic ablative radiation therapy | Surgical resection + lymph node dissection | Does the patient presents metastasis to ipsilateral peribronchial and/or hiliar nodesand intrapulmonar nodes (N1)? | ||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||
chemotherapy + radiation therapy | stereotactic ablative radiation therapy Adjuvant chemotherapy should be added for high-risk stages | ||||||||||||||||||||||||||||||||||||||||||